ESRC press coverage
99.6K views | +7 today
Follow
ESRC press coverage
Your new post is loading...
Your new post is loading...
Scooped by ESRC
Scoop.it!

Cambridge scientists win millions to trial new vaccine against Ebola and other killer viruses | Business Weekly | Technology News | Business news | Cambridge and the East of England

Cambridge scientists win millions to trial new vaccine against Ebola and other killer viruses | Business Weekly | Technology News | Business news | Cambridge and the East of England | ESRC press coverage | Scoop.it
Cambridge University scientists are set to trial a new vaccine designed to counter killer diseases such as Ebola, Marburg and Lassa Fever. Following successful animal trials, the Cambridge team has been awarded £2 million by Innovate UK and the Department of Health and Social Care to take the vaccine to clinical trials in humans. The new vaccine builds on almost two decades of
ESRC's insight:

This article references the Global Challenges Research Fund. 

more...
No comment yet.
Scooped by ESRC
Scoop.it!

The London School of Hygiene & Tropical Medicine is to lead a major project that aims to strengthen the support given to victims of humanitarian crises, such as war or natural disasters.

The London School of Hygiene & Tropical Medicine is to lead a major project that aims to strengthen the support given to victims of humanitarian crises, such as war or natural disasters. | ESRC press coverage | Scoop.it

Funded through The Global Challenges Research Fund (GCRF) Research Councils UK Collective Fund.

ESRC's insight:

The Global Challenges Research Fund is an initiative led by the Department for Business, Energy and Industrial Strategy which operates across a number of delivery partners, including the UK Research Councils.

more...
HEALTH CARE's curator insight, January 14, 11:18 AM
buy-phentermine-online/